Tuesday, January 30, 2018

All Eyez on Me

A More Informed Look at Davis' Open Market Purchases of Publicly Traded Cyanotech Common Stock during 2010-2011
It is well known that Michael Arlen Davis directed and funded RSF’s purchase of VitaeLab’s 9.7% Cyan stake during 2011. This trade, while substantial, was not one discrete opportunistic stock transaction, but a component part of a broader scheme orchestrated by Davis during 2010-2011 to obtain entrenched control of Cyanotech’s board.

Click on the image below to read more:

 Cyanotech Forecast for 2018